TOKYO, Nov 20, 2024 - (JCN Newswire) - - Eisai Co., Ltd. announced today that it has launched fibroblast growth factor receptor (FGFR) selective tyrosine kinase inhibitor "TASFYGO Tablets 35mg" ...

More than a thousand people in England with a specific type of advanced breast cancer could benefit from a new once-a-day tablet following a decision by the National Institute for Health and Care ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. NEW YORK (WWTI) — Pfizer is voluntarily ...

Four lots of the blood pressure medication Quinapril were voluntarily recalled last week by drug manufacturer Lupin Pharmaceuticals Inc. over concerns it could increase the risk of cancer, according ...